Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma.

Lymph node metastasis (LNM) in oral squamous cell carcinoma (OSCC) is known to associate with a significant decrease of 5-year survival. Genetic factors related to the difference of the LNM status in the OSCC have been not fully elucidated. Array-based comparative genomic hybridization (CGH) with individual gene-level resolution and real-time quantitative polymerase chain reaction (QPCR) were conducted using primary tumor materials resected from 54 OSCC patients with (n=22) or without (n=32) cervical LNM. Frequent gain was observed at the 11q13 region exclusively in patients with cervical LNM, which was confirmed by real-time QPCR experiments using 11 genes (TPCN2, MYEOV, CCND1, ORAOV1, FGF4, TMEM16A, FADD, PPFIA1, CTTN, SHANK2 and DHCR7) in this region. It was revealed that two distinct amplification cores existed, which were separated by a breakpoint between MYEOV and CCND1 in the 11q13 region. The combination of copy number amplification at CTTN (core 2) and/or TPCN2/MYEOV (core 1), selected from each core, was most significantly associated with cervical LNM (P=0.0035). Two amplification cores at the 11q13 region may have biological impacts on OSCC cells to spread from the primary site to local lymph nodes. Further study of a larger patient series should be conducted to validate these results.

[1]  Robert Kincaid,et al.  Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[3]  C. Haudenschild,et al.  Cortactin potentiates bone metastasis of breast cancer cells. , 2001, Cancer research.

[4]  Pei Wang,et al.  Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival , 2010, Molecular Cancer.

[5]  Alejandro A Schäffer,et al.  Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.

[6]  Cathie Garnis,et al.  Multiple microalterations detected at high frequency in oral cancer. , 2005, Cancer research.

[7]  A. Bernheim,et al.  Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. , 2002, Human molecular genetics.

[8]  S. Gollin.  Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.

[9]  H. Tideman.  Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor , 1994 .

[10]  J. Myers,et al.  Extent of extracapsular spread , 2003, Cancer.

[11]  E. Feingold,et al.  Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification , 2007, Cytogenetic and Genome Research.

[12]  Ho-Fai Wong,et al.  18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M. Ohira,et al.  Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Shu-Chun Lin,et al.  Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. , 2002, Oral oncology.

[15]  F. Mertens,et al.  Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.

[16]  J. Inazawa,et al.  PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation , 2007, Oncogene.

[17]  G. Snow,et al.  Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma , 1993, Cancer.

[18]  M. Brose,et al.  Genome‐Wide Profiling of Oral Squamous Cell Carcinoma by Array‐Based Comparative Genomic Hybridization , 2006, The Laryngoscope.

[19]  Shu-Chun Lin,et al.  Array‐comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas , 2006, Molecular carcinogenesis.

[20]  S. Weed,et al.  Cortactin: coupling membrane dynamics to cortical actin assembly , 2001, Oncogene.

[21]  K. Omura,et al.  Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[22]  J. Sudbø.  Novel management of oral cancer: a paradigm of predictive oncology. , 2004, Clinical medicine & research.

[23]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[24]  T. Godfrey,et al.  Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma , 2006, Genes, chromosomes & cancer.

[25]  Tzong-Ming Shieh,et al.  Genome‐wide profiling of oral squamous cell carcinoma , 2004, The Journal of pathology.

[26]  D. Beer,et al.  Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Weed,et al.  Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. , 2006, Cancer research.

[28]  S. Petersen,et al.  Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. , 1997, Cancer research.

[29]  F. Toledo,et al.  Gene amplification mechanisms: the role of fragile sites. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  Thomas Ried,et al.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. , 2008, Oral oncology.

[31]  Xin Zeng,et al.  Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features. , 2007, Oral oncology.

[32]  Q. Zhan,et al.  Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. , 2006, Cancer research.

[33]  R. Daly.  Cortactin signalling and dynamic actin networks. , 2004, The Biochemical journal.

[34]  S. Woo,et al.  A comprehensive review of oral cancer. , 2001, General dentistry.

[35]  Chuan-Bin Guo,et al.  Establishment of cervical lymph node metastasis model of squamous cell carcinoma in the oral cavity in mice. , 2008, Chinese medical journal.